Chardan Capital Cuts Notable Labs (NASDAQ:NTBL) Price Target to $5.00

Notable Labs (NASDAQ:NTBLFree Report) had its price objective cut by Chardan Capital from $7.00 to $5.00 in a report published on Thursday, Benzinga reports. They currently have a buy rating on the stock.

Separately, JMP Securities reaffirmed a market outperform rating and set a $9.00 price objective on shares of Notable Labs in a research note on Monday, April 15th.

Read Our Latest Stock Analysis on NTBL

Notable Labs Stock Performance

NTBL opened at $1.02 on Thursday. The company has a fifty day moving average price of $1.33 and a two-hundred day moving average price of $1.85. Notable Labs has a 52 week low of $0.83 and a 52 week high of $11.20. The company has a quick ratio of 5.65, a current ratio of 5.65 and a debt-to-equity ratio of 0.02.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Notable Labs stock. Industry Ventures L.L.C. bought a new position in shares of Notable Labs, Ltd. (NASDAQ:NTBLFree Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 204,424 shares of the company’s stock, valued at approximately $386,000. Notable Labs makes up 0.6% of Industry Ventures L.L.C.’s investment portfolio, making the stock its 6th biggest holding. Industry Ventures L.L.C. owned 9.21% of Notable Labs as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 70.48% of the company’s stock.

Notable Labs Company Profile

(Get Free Report)

Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic.

Featured Stories

Receive News & Ratings for Notable Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Notable Labs and related companies with's FREE daily email newsletter.